|
AU2019276718A1
|
|
Methods for isolating tumor-specific immune cells from a subject for adoptive cell therapy and cancer vaccines
|
|
US2019365699A1
|
|
Treatment of Kidney Tumors by Intratumoral Injection of Taxane Particles
|
|
WO2020072090A1
|
|
Use of antineoplastic agents to stimulate the immune system for production of tertiary lymphoid structures (tls)
|
|
KR20200106911A
|
|
Treatment of bladder cancer by topical administration of taxane particles
|
|
WO2019231499A1
|
|
Use of antineoplastic agents to stimulate the immune system for treatment of cancer
|
|
CN111278436A
|
|
Local delivery of anti-tumor particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer
|
|
EP3687500A1
|
|
Glucocorticoid particles and their use
|
|
US2020247780A1
|
|
Ciprofloxacin polymorph and its use
|
|
CA3063436A1
|
|
Methods for treating lung disorders
|
|
WO2018227037A1
|
|
Treatment of epithelial cysts by intracystic injection of antineoplastic particles
|
|
KR20200137025A
|
|
Methods for Solid Tumor Treatment
|
|
WO2017112930A1
|
|
System and methods for tissue sterilization
|
|
KR20200020995A
|
|
Taxane Particles and Their Use
|
|
AU2015261576A1
|
|
Equipment assembly and method of processing particles
|
|
US2015375153A1
|
|
Equipment assembly for and method of processing particles
|
|
US2015342872A1
|
|
Use of Paclitaxel Particles
|
|
US8778181B1
|
|
Equipment assembly for and method of processing particles
|
|
US2008089944A1
|
|
Method for precipitation of small medicament particles into use containers
|
|
WO03032906A2
|
|
Delivery of poorly soluble drugs
|
